AA |
Arachidonic acid |
15-PGDH |
15-hydroxyprostaglandin dehydrogenase/Prostaglandin Dehydrogenase 1 |
15d-PGJ2 |
15-Deoxy-∆-12,14-prostaglandin J2 |
5-LOX |
5-lipoxygenases |
5 S-HETE |
5S-hydroperoxyeicosatetraenoic acid |
5-OH-PGD2 |
5-hydroxy-prostaglandin D2 |
5-OH-PGE2 |
5-hydroxy-prostaglandin E2 |
AC |
Adenylyl cyclase |
AMI |
Acute myocardial infarction |
ARIC |
Atherosclerosis Risk in Community |
CAD |
Coronary artery disease |
cAMP |
Cyclic adenosine monophosphate |
COX |
Cyclooxygenase |
cPGES |
Cytosolic PGE2 synthase |
CREB |
cAMP response element-binding protein |
CRP |
C-reactive protein |
CRTH2 |
Chemoattractant receptor-homologous molecule expressed on Th2 lymphocytes |
CVD |
Cardiovascular disease |
DP1 |
PGD2 receptor subtype 1 |
EETs |
Epoxyeicosatrienoic acids |
EP |
E-type prostanoid receptor |
ER |
Endoplasmic reticulum |
FP |
Prostaglandin F receptor |
H-PGDS |
Hematopoietic prostaglandin D synthase |
HETEs |
Hydroxyeicosatetraenoic acids |
HKD2 |
Hemiketal D2 |
HKE2 |
Hemiketal E2 |
I/R |
Ischemia/reperfusion |
IL |
Interleukin |
IP |
Prostacyclin receptor |
IP3 |
Inositol trisphosphate |
L-PGDS |
Lipocalin-type prostaglandin D synthase |
MACE |
Major adverse cardiac events |
mPGES |
Microsomal PGE2 synthase |
mPTP |
Mitochondrial permeability transition pore |
NF-κB |
Nuclear factor kappa-light-chain-enhancer of activated B cells |
NSAID |
Non-steroidal anti-inflammatory drug |
PGD2 |
Prostaglandin D2 |
PGE2 |
Prostaglandin E2 |
PGF2α |
Prostaglandin F2α |
PGFS |
Prostaglandin F synthase |
PGG2 |
Prostaglandin G2 |
PGH2 |
Prostaglandin H2 |
PGI2 |
Prostacyclin I2 |
PGIS |
Prostacyclin synthase |
PKA |
Protein kinase A/cAMP-dependent protein kinase |
PLA2 |
Phospholipase A2 |
PPAR |
Peroxisome proliferator-activated receptor |
PUFA |
Polyunsaturated fatty acid |
ROS |
Reactive oxygen species |
SNPs |
Single nucleotide polymorphisms |
TF |
Tissue factor |
TGF-β |
Transforming growth factor β |
Th |
T-helper cells |
TNF-α |
Tumor necrosis factor α |
TP |
Thromboxane prostanoid receptor |
TxA2 |
Thromboxane A2 |
TXAS |
Thromboxane A synthase 1 |
VSMC |
Vascular smooth muscle cell |